Abstract Submissions

American Society of Andrology 51st Annual Conference

April 18-21, 2026
Embassy Suites Scottsdale
Scottsdale, Arizona

Late Breaking Submission Deadline: Sunday, February 8, 2026, at 11:59 pm Eastern Standard Time

  • ASA only accepts electronic abstract submissions via the official abstract submission website.
  • Content should not be presented at another national meeting prior to the ASA Meeting nor be published prior to the abstract submission deadline.
  • A person cannot be the presenting author on more than two abstracts but can be co-author on any number of abstracts. 
  • ASA membership is not required for abstract submission.
  • Basic, clinical and translational scientific abstracts are accepted for submission across the listed abstract category areas.

Abstract Guidelines

  • Word Count limit is 375 words or less excluding title and authors.
  • ONE uploaded image is allowed. Only PNG, TIFF, JPG.
  • Abstracts must be submitted with 4 components: introduction and objectives, methods, results, and conclusions.
  • Financial funding from commercial entities that have an interest in the research must be listed in the disclosure portion of the submission (in the Author section).
  • Oral and Poster presentation types will be offered. Your presentation will be given every consideration; however, final determination will be made by the Program Committee.
  • The following submission categories will be offered; you will need to select the one that best fits your abstract:
      • Androgens/Steroidogenesis/Endocrinology
      • Artificial Intelligence in Reproduction
      • Education in Andrology/Technology-Enhanced Education
      • Environment/Reproductive Pharmacology/Reproductive Toxicology
      • Male Contraception
      • Male Genital Reconstruction
      • Male Infertility/Assisted Reproductive Technology
      • Male Reproductive Health/Clinical Urology/Sexual Dysfunction
      • Male Reproductive Tract Organs (Epididymis/Vas Deferens/Seminal Vesicles/Prostate)
      • Prostate/Testicular Cancer
      • Reproductive Development/Genetics/Aging
      • Reproductive Immunology/Infectious and Inflammatory Diseases
      • Sperm Function/Semen Analysis
      • Testis Biology/Spermatogenesis/Fertilization/Regenerative Medicine
      • Transgender Medicine and Research
  • No reference should be made in the abstract to the names or institutions of the authors.
  • Disclosures for ALL authors/co-authors is required within the submission form as well as their institutions, city, state, country, etc.
  • All accepted abstracts presented at the annual meeting will be published as a supplement in Andrology, the official journal of the American Society of Andrology and the European Academy of Andrology.
  • Announcements of accepted and rejected submissions is planned for late December/early January.

    Abstracts for In-Person Posters/e-Posters

    • In-person poster presentations are interactive ways to connect with your colleagues and showcase your research. When you submit an abstract, you are automatically qualified for a presentation.
    • All applicants with approved abstracts will receive instructions for the in-person posters.

    Declined Abstracts 

    • Please note that conference organizers reserve the right to decline any submitted abstract that lacks scientific content or merit.